Cargando…

The fecal microbiota as a biomarker for disease activity in Crohn’s disease

Monitoring mucosal inflammation is crucial to prevent complications and disease progression in Crohn’s disease (CD). Endoscopy is the current standard, but is invasive. Clinical activity scores and non-invasive biochemical markers do not correlate well with mucosal inflammation. Microbial perturbati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tedjo, Danyta. I., Smolinska, Agnieszka, Savelkoul, Paul H., Masclee, Ad A., van Schooten, Frederik J., Pierik, Marieke J., Penders, John, Jonkers, Daisy M. A. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062155/ https://www.ncbi.nlm.nih.gov/pubmed/27734914 http://dx.doi.org/10.1038/srep35216

Ejemplares similares

The Effect of Sampling and Storage on the Fecal Microbiota Composition in Healthy and Diseased Subjects
por: Tedjo, Danyta I., et al.
Publicado: (2015)

Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn’s Disease
por: Galazzo, Gianluca, et al.
Publicado: (2019)

Fecal Microbial Composition of Ulcerative Colitis and Crohn’s Disease Patients in Remission and Subsequent Exacerbation
por: Wills, Edgar S., et al.
Publicado: (2014)

Impact of Sleeve Gastrectomy on Fecal Microbiota in Individuals with Morbid Obesity
por: Tedjo, Danyta I., et al.
Publicado: (2023)

Corticosteroid enhances epithelial barrier function in intestinal organoids derived from patients with Crohn’s disease
por: Xu, Pan, et al.
Publicado: (2021)

Systematic Review: Contribution of the Gut Microbiome to the Volatile Metabolic Fingerprint of Colorectal Neoplasia
por: van Vorstenbosch, Robert, et al.
Publicado: (2022)

Metagenomic Profiling of Fecal-Derived Bacterial Membrane Vesicles in Crohn’s Disease Patients
por: Kameli, Nader, et al.
Publicado: (2021)

Sugar Beet Pectin Supplementation Did Not Alter Profiles of Fecal Microbiota and Exhaled Breath in Healthy Young Adults and Healthy Elderly
por: An, Ran, et al.
Publicado: (2019)

Modulation of Intestinal Epithelial Permeability by Plasma from Patients with Crohn’s Disease in a Three-dimensional Cell Culture Model
por: Xu, Pan, et al.
Publicado: (2019)

A profile of volatile organic compounds in exhaled air as a potential non-invasive biomarker for liver cirrhosis
por: Pijls, Kirsten E., et al.
Publicado: (2016)

Higher Prevalence of Bacteroides fragilis in Crohn’s Disease Exacerbations and Strain-Dependent Increase of Epithelial Resistance
por: Becker, Heike E. F., et al.
Publicado: (2021)

High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score
por: Bodelier, Alexander G. L., et al.
Publicado: (2016)

Disease Activity Patterns of Crohn’s Disease in the First Ten Years After Diagnosis in the Population-based IBD South Limburg Cohort
por: Wintjens, Dion, et al.
Publicado: (2020)

A novel biomarker panel for irritable bowel syndrome and the application in the general population
por: Mujagic, Zlatan, et al.
Publicado: (2016)

Inter-kingdom relationships in Crohn’s disease explored using a multi-omics approach
por: Frau, Alessandra, et al.
Publicado: (2021)

Does Day-to-Day Variability in Stool Consistency Link to the Fecal Microbiota Composition?
por: Vork, Lisa, et al.
Publicado: (2021)

The reproducibility of skeletal muscle signal intensity on routine magnetic resonance imaging in Crohn's disease
por: Spooren, Corinne E.G.M., et al.
Publicado: (2020)

Fecal microbiota transplantation for refractory Crohn's disease
por: Bak, Seon Ho, et al.
Publicado: (2017)

Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn’s Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature
por: Smeets, Fabiënne G M, et al.
Publicado: (2019)

Histopathological Features in Colonic Biopsies at Diagnosis Predict Long-term Disease Course in Patients with Crohn’s Disease
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2021)

Detecting Colorectal Adenomas and Cancer Using Volatile Organic Compounds in Exhaled Breath: A Proof-of-Principle Study to Improve Screening
por: Cheng, Hao Ran, et al.
Publicado: (2022)

Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease
por: Becker, Heike E. F., et al.
Publicado: (2023)

Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn’s disease
por: Strömbeck, Anna, et al.
Publicado: (2020)

Distinct alterations of fecal microbiota refer to the efficacy of adalimumab in Crohn’s disease
por: Chen, Liang, et al.
Publicado: (2022)

Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial
por: Janssen, Laura, et al.
Publicado: (2021)

Diet Quality and Dietary Inflammatory Index in Dutch Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients
por: de Graaf, Marlijne C. G., et al.
Publicado: (2022)

The Involvement of Intestinal Tryptophan Metabolism in Inflammatory Bowel Disease Identified by a Meta-Analysis of the Transcriptome and a Systematic Review of the Metabolome
por: Wang, Shan, et al.
Publicado: (2023)

The Impact of NOD2 Variants on Fecal Microbiota in Crohn’s Disease and Controls Without Gastrointestinal Disease
por: Kennedy, Nicholas A, et al.
Publicado: (2018)

The Impact of Pectin Supplementation on Intestinal Barrier Function in Healthy Young Adults and Healthy Elderly
por: Wilms, Ellen, et al.
Publicado: (2019)

Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn’s Disease Patients
por: Doherty, Matthew K., et al.
Publicado: (2018)

Fecal microbiota transplantation cured epilepsy in a case with Crohn’s disease: The first report
por: He, Zhi, et al.
Publicado: (2017)

Fecal fungal microbiota alterations associated with clinical phenotypes in Crohn’s disease in southwest China
por: Zeng, Li, et al.
Publicado: (2022)

Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta‐analysis
por: De Munck, Toon J. I., et al.
Publicado: (2020)

Prediction of Inflammatory Bowel Disease Course Based on Fecal Scent
por: Bosch, Sofie, et al.
Publicado: (2022)

The Safety of Fecal Microbiota Transplantation for Crohn’s Disease: Findings from A Long-Term Study
por: Wang, Honggang, et al.
Publicado: (2018)

Severe Ileocolonic Crohn’s Disease Flare Associated with Fecal Microbiota Transplantation Requiring Diverting Ileostomy
por: Tran, Vivy, et al.
Publicado: (2018)

Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study
por: Sokol, Harry, et al.
Publicado: (2020)

Risk of Fecal Diversion in Complicated Perianal Crohn’s Disease
por: Mueller, M. H., et al.
Publicado: (2007)

In vitro metabolic capacity of carbohydrate degradation by intestinal microbiota of adults and pre-frail elderly
por: An, Ran, et al.
Publicado: (2021)

Severe COVID-19 in inflammatory bowel disease patients in a population-based setting
por: Creemers, Rob H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_02qfecd60mmsduq2ui47dto4ko